• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Adjunctive Tirofiban Associated With Improved Myocardial Perfusion and Ventricular Function in STEMI

by
November 10, 2026
in Health
Reading Time: 3 mins read
0
Adjunctive Tirofiban Associated With Improved Myocardial Perfusion and Ventricular Function in STEMI

Adjunctive Tirofiban Associated With Improved Myocardial Perfusion and Ventricular Function in STEMI

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Adjunctive administration of tirofiban during primary percutaneous coronary intervention is associated with enhanced myocardial tissue perfusion and improved left ventricular functional recovery in patients with ST-segment elevation myocardial infarction, according to a retrospective evaluation. The investigation, conducted by researchers at Zhangjiakou First Hospital in Hebei, China, examined patients presenting with ST-segment elevation myocardial infarction who underwent urgent catheter-based revascularization. By combining conventional angiographic evaluations with advanced three-dimensional echocardiography and laboratory biomarker assays, the clinical team analyzed whether adding tirofiban to standard primary percutaneous coronary intervention provided measurable microvascular and functional benefits over mechanical intervention alone.

The retrospective analysis initially reviewed medical records from 114 eligible patients diagnosed with ST-segment elevation myocardial infarction who were treated with primary percutaneous coronary intervention between March 2024 and May 2025. Among the overall cohort, 61 individuals had undergone coronary intervention alone, whereas 53 patients had received adjunctive tirofiban alongside the standard catheter procedure. To minimize selection bias and balance baseline characteristics between the two treatment strategies, the investigators implemented a one-to-one propensity score matching protocol. This matching procedure successfully produced 48 matched pairs, establishing a balanced cohort of 96 patients whose general baseline data exhibited no statistically significant differences between the two treatment arms, thereby confirming the comparability of the cohorts before comparing subsequent clinical trajectories.

To evaluate myocardial recovery with high anatomical and functional precision, the investigators employed complementary diagnostic modalities focusing on both tissue-level microvascular blood flow and global ventricular performance. Myocardial perfusion was assessed using angiographic myocardial blush grade. Concurrently, left ventricular functional recovery was quantified by capturing three-dimensional echocardiographic full-volume datasets, which were subsequently analyzed offline using TomTec computational software to establish left ventricular ejection fraction. Before treatment, baseline values for myocardial blush grade and left ventricular ejection fraction demonstrated statistical comparability across both groups with P-values greater than 0.05, confirming equivalent initial degrees of circulatory and myocardial compromise.

Following therapeutic intervention, both patient cohorts exhibited demonstrable changes from their pre-procedure baselines, but the magnitude of recovery was significantly greater among patients who received adjunctive tirofiban. In post-treatment assessments, the myocardial blush grade reached an average score of 2.42 ± 1.02 in the tirofiban group compared with 1.58 ± 0.88 in the control group, representing a statistically significant difference with a between-group P-value of less than 0.001. Parallel gains were documented in systolic function, as three-dimensional echocardiographic analysis revealed that left ventricular ejection fraction rose to 55.74 ± 3.12 percent in the tirofiban-treated cohort compared to 48.89 ± 5.17 percent in the conventional intervention cohort, also achieving statistical significance at a P-value of less than 0.001 for between-group comparisons of changes.

Baseline concentrations of cardiac troponin I, superoxide dismutase, and endothelin had been comparable between the two groups prior to treatment, and both arms showed significant changes after therapy. However, post-treatment levels of cardiac troponin I, a highly specific marker of ongoing myocardial injury, were significantly lower in patients receiving adjunctive tirofiban than in those managed with intervention alone, averaging 12.34 ± 1.76 compared to 16.73 ± 1.98. Furthermore, the treatment group showed greater improvements in superoxide dismutase levels than the control group (P < 0.001). The treatment group also showed greater improvements in endothelin levels than the control group (P < 0.001).

The research team systematically tracked major adverse cardiac events, a composite clinical endpoint encompassing cardiac death, recurrent myocardial infarction, hospital admission for worsening heart failure, and unplanned target-vessel revascularization.

Subject of Research: Adjunctive tirofiban during primary percutaneous coronary intervention for myocardial infarction

Article Title: Effects of adjunctive tirofiban during PCI on myocardial perfusion and ventricular function in myocardial infarction: a 3D echocardiography-based evaluation

Article References: Wang, X., Han, Y., & Zhang, C. (2026). Effects of adjunctive tirofiban during PCI on myocardial perfusion and ventricular function in myocardial infarction: a 3D echocardiography-based evaluation. Frontiers in Cardiovascular Medicine, 13, Article 1857341. https://doi.org/10.3389/fcvm.2026.1857341

Image Credits: AI Generated

DOI: 10.3389/fcvm.2026.1857341

Keywords: Tirofiban, Percutaneous coronary intervention, Myocardial infarction, STEMI, Three-dimensional echocardiography, Myocardial blush grade, Left ventricular ejection fraction, Propensity score matching, Effects, adjunctive, during, myocardial

News Source: Ophelia Keating. (November 10, 2026). Adjunctive Tirofiban Associated With Improved Myocardial Perfusion and Ventricular Function in STEMI. Scienmag.

Tags: Adjunctiveduringeffectsleft ventricular ejection fractionmyocardialMyocardial blush gradeMyocardial InfarctionPercutaneous Coronary Interventionpropensity score matchingSTEMIthree-dimensional echocardiographytirofiban
Share12Tweet7Share2ShareShareShare1

Related Posts

Simulated Taekwondo Match Fatigue Does Not Alter Balance in Female Athletes

Simulated Taekwondo Match Fatigue Does Not Alter Balance in Female Athletes

November 16, 2026
Systematic Review Finds Leprosy Frequently Mimics Systemic Lupus Erythematosus Across Clinical Presentations

Systematic Review Finds Leprosy Frequently Mimics Systemic Lupus Erythematosus Across Clinical Presentations

November 16, 2026

Uric Acid-to-Creatinine Ratio Linked to Mortality Risk in Heart Disease Patients

November 16, 2026

High-Dose Manidipine Reduces Albuminuria in Hypertensive Chronic Kidney Disease Patients

November 16, 2026

POPULAR NEWS

  • USMLE Intentions Are Linked to Perceived Stress Among Pakistani Medical Students

    USMLE Intentions Are Linked to Perceived Stress Among Pakistani Medical Students

    29 shares
    Share 12 Tweet 7
  • Leather Waste Yields Fluorescent Nanodots for Bioinspired Multifunctional Sensing Hydrogels

    29 shares
    Share 12 Tweet 7
  • Free-Living Amoebae May Act as Reservoirs and Amplifiers of Antibiotic Resistance

    29 shares
    Share 12 Tweet 7
  • Lower Prognostic Nutritional Index Linked to Higher Stroke Pneumonia Risk in Study

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Novel Schiff Base Fluorescent Probe Enables Dual-Ion Detection and Cell Imaging

Simulated Taekwondo Match Fatigue Does Not Alter Balance in Female Athletes

Systematic Review Finds Leprosy Frequently Mimics Systemic Lupus Erythematosus Across Clinical Presentations

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.